Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: A prospective placebo-controlled study

Human Reproduction

Volumn 21, Issue 7, 2006, Pages 1805-1808

  Elnashar, Aboubakr ^a,b   Abdelmageed, Emad ^a   Fayed, Mahmod ^a   Sharaf, Magdy ^a  

^a Benha University   (Egypt)

^b NONE   (Egypt)

Author keywords

Anovulation; Clomiphene citrate; Dexamethazone; Infertility; Polycystic ovary syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; DEXAMETHASONE; DEXAZONE; FOLIC ACID; PLACEBO; PRASTERONE SULFATE;

ABSENCE OF SIDE EFFECTS; ADULT; AGE; AMENORRHEA; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; ENDOMETRIUM; FEMALE; FEMALE INFERTILITY; HIRSUTISM; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; OLIGOMENORRHEA; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; SEXUAL INTERCOURSE; SHORT COURSE THERAPY; THICKNESS; TRANSVAGINAL ECHOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME; WAIST HIP RATIO;

EID: 33745839702     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del053     Document Type: Article

References (24)

1. Azziz R, Black V, Knochenhauer E, Hines G and Boots L (1999) Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. J Clin Endocrinol Metab 84,946-950.
2. Beck JI, Boothroyd C, Proctor M, Farquhar C and Hughes E (2005) Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev 1,CD002249.
3. Branigan ME and Estes A (1999) Using oral contraceptives as a treatment for clomid-resistant patients. Fertil Steril 71,544-546.
4. Casanueva FF, Burguera B, Muruais C and Dieguez C (1990) Acute administration of glucocorticoids: A new and peculiar stimulus to growth hormone secretion in man. J Clin Endocrinol Metab 70,234-237.
5. Casterlin S, Hide B, Houserman VL, Long CA and Honea KL (2001) Evaluation of effect of endometrial thickness on pregnancy outcome with clomiphene citrate induced pregnancy. Fertil Steril 76,S185-S186.
6. Daly DC, Walters CA, Soto-Albors CE, Tohan N and Riddick DH (1984) A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril 41,844-848.
7. Diamant YZ and Evron S (1981) Induction of ovulation by combined clomiphene citrate and dexamethasone treatment in clomiphene citrate nonresponders. Eur J Obstet Gynecol Reprod Biol 11,335-340.
8. Felemban A, Tan SL and Tulandi T (2000) Laparoscopic treatment of polycystic ovary syndrome with insulated needle cautery, a reappraisal. Fertil Steril 73,266-269.
9. Hoffman D and Lobo RA (1985) Serum dehydroepiandrosterone sulfate and the use of clomiphene citrate in anovulatory women. Fertil Steril 43,196-199.
10. Isaacs JD Jr, Lincoln SR and Cowan BD (1997) Extended clomiphene citrate (CC) and prednisone for the treatment of chronic anovulation resistant to CC alone. Fertil Steril 67,641-643.
11. Kim LH, Taylor AE and Barbieri RL (2000) Insulin sensitizers and polycystic ovary syndrome; can a diabetes medication treat infertility? Fertil Steril 73,1097-1098.
12. Kousta E, White DM and Franks S (1997) Modem use of clomiphene citrate in induction of ovulation. Hum Reprod Update 3,359-362.
13. Lidor AL, Goldenberg M, Cohen SB, Seidman DS, Mashiach S and Rabinovici J (2000) Management of women with polycystic ovary syndrome who experienced premature luteinization during clomiphene citrate treatment. Fertil Steril 74,749-752.
14. Lobo RA, Paul W, March CM, Granger L and Kletzky OA (1982) Clomiphene and dexamethasone in women unresponsive to clomiphene alone. Obstet Gynecol 60,497-501.
15. March CM (1990) Human menopausal gonadotropins. Infertil Reprod Mod Clin North Am 1,59-78.
16. Miell JP, Taylor AM, Jones J et al. (1993) The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J Endocrinol 136,525-533.
17. Parsanezhad ME, Albozi S, Motazedian S and Gholamhossein (2002) Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: A prospective, double-blind, placebo-controlled trial. Fertil Steril 78,1001-1004.
18. Polak de Fried E, Blanco L, Lancuba S et al. (1993) Improvement of clinical pregnancy rate and implantation rate of in-vitro fertilization-embryo transfer patients by using methylprednisolone. Hum Reprod 8,393-395.
19. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81,19-25.
20. Roy S, Wang J and Yang P (2003) Dexamethasone inhibits transforming growth factor-β receptor (T β R) mRNA expression in hamster preantral follicles: Possible association with NF-YA. Biol Repod 68,2180-2188.
21. Smith EP, Boyd J, Frank GR, Howe DM, Hurd WW, Randolph Jr. et al. (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 221,1056-1061.
22. Terakawa N, Shimizu I, Aono T, Tanizawa O and Matsumoto K (1985) Dexamethasone suppresses estrogen action at the pituitary level without modulating estrogen receptor dynamics. J Steroid Biochem 23,385-388.
23. Trott EA, Plouffe Jr L, Hansen K, Hines R, Brann DW and Mahesh VB (1996) Ovulation induction in clomiphene resistant anovulatory women with normal dehydroepiandrosterone sulfate levels; beneficial effects of the addition of dexamethasone during the follicular phase. Fertil Steril 66,484-487.
24. Yen SS (1991) Chronic anovulation caused by peripheral endocrine disorders. In Yen SS and Jaffe RB (eds.) Reproductive Endocrinology; Physiology, Pathophysiology, and Clinical Management, 3rd edn. Philadelphia, Saunders, pp. 576-630.